These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

246 related articles for article (PubMed ID: 38203704)

  • 1. Developing Pharmacological Therapies for Atrial Fibrillation Targeting Mitochondrial Dysfunction and Oxidative Stress: A Scoping Review.
    Menezes Júnior ADS; França-E-Silva ALG; Oliveira JM; Silva DMD
    Int J Mol Sci; 2023 Dec; 25(1):. PubMed ID: 38203704
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of oxidative stress in the pathogenesis and perpetuation of atrial fibrillation.
    Korantzopoulos P; Kolettis TM; Galaris D; Goudevenos JA
    Int J Cardiol; 2007 Feb; 115(2):135-43. PubMed ID: 16764958
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Costunolide ameliorates angiotensin II-induced atrial inflammation and fibrosis by regulating mitochondrial function and oxidative stress in mice: A possible therapeutic approach for atrial fibrillation.
    Liu Y; Wang D; Jin Y; Sun G; Lou Q; Wang H; Li W
    Microvasc Res; 2024 Jan; 151():104600. PubMed ID: 37666318
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tracing the origins of postoperative atrial fibrillation: the concept of oxidative stress-mediated myocardial injury phenomenon.
    Elahi MM; Flatman S; Matata BM
    Eur J Cardiovasc Prev Rehabil; 2008 Dec; 15(6):735-41. PubMed ID: 19020458
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mitochondrial dysfunction as an arrhythmogenic substrate: a translational proof-of-concept study in patients with metabolic syndrome in whom post-operative atrial fibrillation develops.
    Montaigne D; Marechal X; Lefebvre P; Modine T; Fayad G; Dehondt H; Hurt C; Coisne A; Koussa M; Remy-Jouet I; Zerimech F; Boulanger E; Lacroix D; Staels B; Neviere R
    J Am Coll Cardiol; 2013 Oct; 62(16):1466-73. PubMed ID: 23644086
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and mitochondrial mechanisms of atrial fibrillation.
    Mason FE; Pronto JRD; Alhussini K; Maack C; Voigt N
    Basic Res Cardiol; 2020 Nov; 115(6):72. PubMed ID: 33258071
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Attenuating persistent sodium current-induced atrial myopathy and fibrillation by preventing mitochondrial oxidative stress.
    Avula UMR; Dridi H; Chen BX; Yuan Q; Katchman AN; Reiken SR; Desai AD; Parsons S; Baksh H; Ma E; Dasrat P; Ji R; Lin Y; Sison C; Lederer WJ; Joca HC; Ward CW; Greiser M; Marks AR; Marx SO; Wan EY
    JCI Insight; 2021 Oct; 6(23):. PubMed ID: 34710060
    [TBL] [Abstract][Full Text] [Related]  

  • 8. NADPH Oxidases and Oxidative Stress in the Pathogenesis of Atrial Fibrillation.
    Ramos-Mondragón R; Lozhkin A; Vendrov AE; Runge MS; Isom LL; Madamanchi NR
    Antioxidants (Basel); 2023 Oct; 12(10):. PubMed ID: 37891912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oxidative damage to mitochondrial DNA in atrial muscle of patients with atrial fibrillation.
    Lin PH; Lee SH; Su CP; Wei YH
    Free Radic Biol Med; 2003 Nov; 35(10):1310-8. PubMed ID: 14607530
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms and Treatments of Oxidative Stress in Atrial Fibrillation.
    Ren X; Wang X; Yuan M; Tian C; Li H; Yang X; Li X; Li Y; Yang Y; Liu N; Shang H; Gao Y; Xing Y
    Curr Pharm Des; 2018; 24(26):3062-3071. PubMed ID: 30179130
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective downregulation of mitochondrial electron transport chain activity and increased oxidative stress in human atrial fibrillation.
    Emelyanova L; Ashary Z; Cosic M; Negmadjanov U; Ross G; Rizvi F; Olet S; Kress D; Sra J; Tajik AJ; Holmuhamedov EL; Shi Y; Jahangir A
    Am J Physiol Heart Circ Physiol; 2016 Jul; 311(1):H54-63. PubMed ID: 27199126
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Antioxidants for prevention of atrial fibrillation: a potentially useful future therapeutic approach? A review of the literature and meta-analysis.
    Violi F; Pastori D; Pignatelli P; Loffredo L
    Europace; 2014 Aug; 16(8):1107-16. PubMed ID: 24706090
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mitochondrial oxidative stress promotes atrial fibrillation.
    Xie W; Santulli G; Reiken SR; Yuan Q; Osborne BW; Chen BX; Marks AR
    Sci Rep; 2015 Jul; 5():11427. PubMed ID: 26169582
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mitochondria and the Pathophysiological Mechanism of Atrial Fibrillation.
    Li X; Yang X; Li Y; Yuan M; Tian C; Yang Y; Zhang X; Liu C; Gao Y; Liu N; Shang H; Xing Y
    Curr Pharm Des; 2018; 24(26):3055-3061. PubMed ID: 30179127
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Molecular Mechanism of the Association Between Atrial Fibrillation and Heart Failure Includes Energy Metabolic Dysregulation Due to Mitochondrial Dysfunction.
    Ozcan C; Li Z; Kim G; Jeevanandam V; Uriel N
    J Card Fail; 2019 Nov; 25(11):911-920. PubMed ID: 31415862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Oxidative stress: a possible pathogenesis of atrial fibrillation.
    Huang CX; Liu Y; Xia WF; Tang YH; Huang H
    Med Hypotheses; 2009 Apr; 72(4):466-7. PubMed ID: 19103473
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impact of aldosterone antagonists on the substrate for atrial fibrillation: aldosterone promotes oxidative stress and atrial structural/electrical remodeling.
    Mayyas F; Alzoubi KH; Van Wagoner DR
    Int J Cardiol; 2013 Oct; 168(6):5135-42. PubMed ID: 23993726
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Redox control of cardiac remodeling in atrial fibrillation.
    Wolke C; Bukowska A; Goette A; Lendeckel U
    Biochim Biophys Acta; 2015 Aug; 1850(8):1555-65. PubMed ID: 25513966
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Atrial fibrillation: the emerging role of inflammation and oxidative stress.
    Negi S; Sovari AA; Dudley SC
    Cardiovasc Hematol Disord Drug Targets; 2010 Dec; 10(4):262-8. PubMed ID: 20932266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implications of SGLT Inhibition on Redox Signalling in Atrial Fibrillation.
    Bode D; Semmler L; Oeing CU; Alogna A; Schiattarella GG; M Pieske B; Heinzel FR; Hohendanner F
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073033
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.